Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
Orexigen: Don't Count Contrave Out Yet
Seeking Alpha
Fri, 12/3/10 - 06:45 am
FDA
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Vivus
Orexigen Options Suggest Contrave Diet Pill May Avoid Arena, Vivus Delays
Bloomberg
Thu, 12/2/10 - 10:17 am
Orexigen
options
Contrave
obesity
Vivus
Arena Pharmaceuticals
Allergan Lap-Band Effective in Treating More Obese People, FDA Staff Says
Bloomberg
Wed, 12/1/10 - 11:29 am
Allergan
obesity
Lap-Band
FDA
Orexigen: Contrave FDA Panel Preview
TheStreet.com
Tue, 11/30/10 - 08:02 am
FDA
advisory panels
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Vivus
Obesity Drug Risks Prompt New Wide-Reaching EU Drug Data Disclosure Rule
Bloomberg
Fri, 11/19/10 - 11:14 am
obesity
Europe
Acomplia
Sanofi
Arena touts new obesity data as it campaigns for quick OK
Fierce Biotech
Tue, 11/9/10 - 08:59 am
obesity
Arena Pharmaceuticals
diabetes
Diet Drug Optimism Lifts Shares of Vivus
NY Times
Sat, 10/30/10 - 12:14 pm
Vivus
Qnexa
obesity
Vivus Gains on Potential to Win U.S. Clearance for Obesity Drug Next Year
Bloomberg
Fri, 10/29/10 - 11:49 am
Qnexa
FDA
obesity
Vivus
Whither Diet Pills? Why The FDA Keeps Saying No
Pharmalot
Fri, 10/29/10 - 11:46 am
Vivus
Qnexa
obesity
diet pills
Arena Pharmaceuticals
FDA
Vivus Fails to Win U.S. Approval for Diet Pill Qnexa on Safety Concerns
Bloomberg
Thu, 10/28/10 - 10:17 pm
FDA
diet drugs
Qnexa
Vivus
obesity
Long Odds Seen For Diet Drugs
WSJ Online
Tue, 10/26/10 - 12:37 pm
obesity
Arena Pharmaceuticals
Eisai
Orexigen
Contrave
Timeline: A look back at Arena's lorcaserin
Fierce Biotech
Mon, 10/25/10 - 12:35 pm
obesity
Arena Pharmaceuticals
Arena Obesity Drug Faces Uncertain Future
The Street
Sun, 10/24/10 - 01:08 pm
Arena Pharmaceuticals
obesity
FDA Rejects Arena Obesity Drug
Forbes
Sat, 10/23/10 - 11:18 am
FDA
obesity
Arena Pharmaceuticals
FDA to Decide Obesity Drug Lorcaserin's Fate
WSJ Online
Fri, 10/22/10 - 07:25 am
FDA
obesity
Arena Pharmaceuticals
Will The Meridia Withdrawal Help Or Hurt Diet Pills?
Pharmalot
Mon, 10/11/10 - 11:08 am
Abbott Laboratories
Meridia
obesity
diet drugs
Arena investors fight back against FDA
San Diego Union Tribune, CA
Sun, 10/10/10 - 12:11 pm
Arena Pharmaceuticals
obesity
Orexigen Shares Popped: What You Need to Know
Motley Fool
Thu, 10/7/10 - 06:04 pm
Orexigen
obesity
Arena Pharmaceuticals
Vivus
Why The FDA Keeps Rejecting Obesity Pills
Forbes
Mon, 10/4/10 - 05:19 pm
FDA
obesity
Arena Pharmaceuticals
Lorqess
Vivus
Qnexa
Arena Pharmaceuticals Investors Smell A Rat
Pharmalot
Mon, 10/4/10 - 11:24 am
Arena Pharmaceuticals
investors
Lorqess
obesity
FDA
advisory panels
Pages
« first
‹ previous
…
37
38
39
40
41
42
43
44
45
…
next ›
last »